Methylphenidate: use in daily practice
- PMID: 16096887
- DOI: 10.1007/s11096-004-2848-1
Methylphenidate: use in daily practice
Abstract
Objective: With the aim of getting more insight into compliance of children using methylphenidate, we studied the day-to-day use of the drug. In addition, the efficacy and side effects of treatment, stopping, switching to other drugs and the use of additional psychoactive drugs in daily practice were studied.
Method: On the basis of pharmacy records, the use of methylphenidate by 52 children was studied. Two parameters for compliance were calculated. By means of a questionnaire, parents were asked about their children's compliance with the use of methylphenidate as well as about their experience with treatment.
Main outcome measure: Compliance, use of methylphenidate in weekends and holidays, self-reported efficacy, side effects, stopping and switching to other drugs.
Results: Depending on the parameter calculated, the percentage of children with a good compliance varied from 25 to 47%. About 65% of the children used less or no methylphenidate in the weekends and holidays. Sixty-five percent of the parents reported to pass over a dose once in a while. According to 61% of the parents (n = 28) the efficacy of methylphenidate was good or very good. Nine (33%) of 28 children stopped using methylphenidate. Seven children stopped using the drug because of side-effects or lack of efficacy. Seven children switched to other psychoactive drugs. Fifty-seven percent of all children used additional psychoactive drugs.
Conclusion: The percentage of children having a good compliance calculated on the basis of pharmacy records is rather low. This is partly the result of the decreased use of methylphenidate in the weekends and holidays.
Similar articles
-
Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial.J Child Adolesc Psychopharmacol. 2004 Summer;14(2):195-206. doi: 10.1089/1044546041649066. J Child Adolesc Psychopharmacol. 2004. PMID: 15319017 Clinical Trial.
-
Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x. Psychiatry Clin Neurosci. 2009. PMID: 19335386 Clinical Trial.
-
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. doi: 10.1016/j.pnpbp.2007.03.018. Epub 2007 Apr 1. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17493730 No abstract available.
-
Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):41-50. doi: 10.1176/jnp.3.1.41. J Neuropsychiatry Clin Neurosci. 1991. PMID: 7580171 Review.
-
[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].Harefuah. 2011 Oct;150(10):788-90, 814. Harefuah. 2011. PMID: 22111124 Review. Hebrew.
Cited by
-
Antipsychotic Drug Prescribing in Children Previously Treated With Stimulants for ADHD: A Population-Based Longitudinal Study: La prescription d'antipsychotiques chez les enfants précédemment traités avec des stimulants pour le TDAH : une étude longitudinale basée sur la population.Can J Psychiatry. 2025 May;70(5):382-391. doi: 10.1177/07067437241309679. Epub 2025 Jan 17. Can J Psychiatry. 2025. PMID: 39819175 Free PMC article.
-
European guidelines on managing adverse effects of medication for ADHD.Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3. Eur Child Adolesc Psychiatry. 2011. PMID: 21042924 Free PMC article.
-
What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research.Atten Defic Hyperact Disord. 2018 Dec;10(4):273-283. doi: 10.1007/s12402-018-0258-9. Epub 2018 Jul 7. Atten Defic Hyperact Disord. 2018. PMID: 29982921 Free PMC article.
-
Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.Medscape J Med. 2008 Jan 8;10(1):5. Medscape J Med. 2008. PMID: 18324315 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical